Le Lézard
Classified in: Mining industry, Science and technology, Business, Covid-19 virus
Subject: STR

3DM (3DM Digital Manufacturing) raised $13 Million and begun trading on the Tel Aviv Stock Exchange under the symbol DM3


TEL AVIV, Israel, June 23, 2021 /PRNewswire/ -- 3DM (TASE: DM3), which operates in the field of plastic polymers industrial 3D printing, has successfully completed an IPO in Tel Aviv Stock Exchange and begun trading yesterday, Monday, June 21, 2021. The company  has raised $13 Million in a Pre-IPO & IPO rounds from several institutional entities which include Mor, Psagot, Phoenix, Meitav and Sphera. The IPO's underwriter was Rosario Underwriter Services.

3DM operates in the field of plastic polymer industrial 3D printing. The technology and the product that the company has developed will enable the next leap in the industrial 3D printing world by opening the market to an enormous range of applications as a result of expanding the material library availability to industrial printing, improvement of the mechanical characteristics of the printed component, and significant reduction of the printing costs.

The automotive and aviation industries, for example, are some of the largest adopters of plastic 3D printing technology for industrial needs. Thus, a car manufacturer may supply spare parts for a large variety of car model's body by keeping a 'digital warehouse' from which spare parts may be printed, and send them to the customer within a few days. The supplier is thus able to save on storage and inventory management costs while maintaining a high level of customer service with "inventory on demand".

The consumer goods industry also aims to utilize the innovation of industrial printing to develop a range of custom-made products such as shoes, helmets, bike seats, glasses and more. This trend is expected to greatly increase the use of industrial 3D printers.

The company's core technology is its self-developed semiconductor laser component for 3D printing. The company uses these components for optimal melting of all thermoplastic material families. Its small size (several millimeters), high power, low manufacturing cost has allowed the company to design a new printhead which combines many dozens of laser components into a matrix of laser beams that accelerate printing speed. The company has a registered patent for the use of its laser technology in plastic polymer 3D printing.

The company's controlling shareholders are Terralab Ventures and Dr. Daniel Majer. Dr. Majer holds a Ph.D. in physics from the Weizmann Institute of Science and has over 25 years of experience in the development of electro-optic components. He has engaged in the development of lasers since 2005 and in the development of 3D printing technology since 2012. The company started out as an incubator company of Terralab Ventures which, after the IPO, holds around 23% of the company's shares.

Before the IPO, the company raised funds from Terralab Ventures, AM Venture Group (US based strategic private group) and a private Israeli investors group. The company is located in Rosh HaAyin, Israel.

3DM's printhead capabilities:

The need for technological innovation:

The plastics market has for decades made extensive use of plastic injection molding for a broad range of applications. In 2019, the global plastics manufacturing market was valuedaround $570 billion. Despite the demand in the market for industrial printing solutions, the market share of industrial printing is a few percent due to insufficient technological innovation alongside the high costs of printers and raw materials. 3DM estimates that the printhead developed by the company brings to the market the technological innovation that will enable many more manufacturers and customers to make use of 3D technology for printing industrial products on a larger-than-ever scale and at lower costs, resulting in a significant increase in the industrial printing's market share in the plastics manufacturing market.

Technology penetration catalysts:

The global Covid-19 pandemic led to significant disruptions in the supply chain with an emphasis on the supply of products from the East to the West, causing difficulties in the supply of both raw materials and products, and consequently many manufacturers, with the support of their countries, are exploring the possibility of repatriating the manufacturing of all or part of the finished product to domestic manufacturing centers. As Aan example the U.S. Administration launched a $2 trillion incentive program which marks a trend of development and transfer of manufacturing abilities to the U.S. from countries where significant manufacturing has been carried out until now. The company believes that this trend may lead to a rise in the demand for 3D manufacturing in fields which, until now, had been manufactured outside of the U.S., including consumer goods and parts for the automotive and aviation industries.

Visit: https://www.3dm-tech.co.il/

Contact
Daviv Ben Naim
[email protected]

 

SOURCE 3DM


These press releases may also interest you

at 17:50
The global feminine hygiene wash market  size is estimated to grow by USD 124.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 5.17%  during the forecast period.  Advertising and promotion of...

at 17:30
The global marine loading arms market size is estimated to grow by USD 65.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 3.43%  during the forecast period. Rise in demand for oil and gas...

at 17:01
The global payment gateways market size is estimated to grow by USD 11.23 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 13.42%  during the forecast period.  High adoption of contactless payment...

at 16:50
The global wellness real estate market size is estimated to grow by USD 1.26 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 32.14% during the forecast period. Rising demand for wellness real estate from...

at 16:35
Navidea Biopharmaceuticals, Inc. ("Navidea" or the "Company"), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced disappointing results of an exploratory analysis conducted on the...

at 16:10
The global consumer healthcare market size is estimated to grow by USD 170.2 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 6.78% during the forecast period. Awareness about lifestyle diseases is driving...



News published on and distributed by: